Introduction

1
Metabolic engineering has proven to be tremendously important for sustainable 2 production of fuels 1,2 , chemicals 3, 4 , and pharmaceuticals 5, 6 . One of the critical steps in metabolic 3 engineering is reprogramming metabolic fluxes in host cells to optimize the fermentation 4 performance such as product yield 7, 8 . To achieve this goal, several enzymes need to be activated 5 while in the meantime others need to be repressed 9 . The multiplex and multi-directional control 6 of enzyme expressions is largely executed through transcriptional regulation [9] [10] [11] [12] . Recently, the 7 type-II clustered regularly interspaced short palindromic repeats (CRISPR)/Cas9 from expressions of multiple genes at multiple directions (i.e., both activation and repression).
13
Although demonstrating great promises in controlling metabolic fluxes, the current 14 CRISPR-based transcription regulation faces several challenges when being applied for 15 metabolic engineering. First, it relies on a panel of well-characterized genetic parts (e.g., RNA-
16
binding proteins) to achieve the transcriptional regulation 9, 20 . However, the rareness of such 17 genetic parts often limits the application of current CRISPR-based transcription regulator in a 18 metabolic network. Second, it requires the co-expression of effector proteins to activate or 19 repress the target genes 9, 20 . Therefore, the utility of current CRISPR-based transcription minimal protein expression to achieve multi-directional gene regulation.
1
In this study, we have developed a data-driven approach that enables the rational design 2 of a new type of CRISPR-based transcription regulation. This CRISPR-based transcription 3 regulator uses only a fused protein of a nuclease-deficient Cas9 (dCas9) and an effector (VP64) 4 to achieve multi-directional and multiplex gene regulation, which eliminates the metabolic costs 5 associated with the expression of effector proteins in previous studies 9, 20 . We found that the 6 deployment of guide RNAs was the key factor that determined the regulatory effects of our 7 CRISPR-based transcription regulator. We used a data-driven approach to provide accurate and 8 target-oriented guidance on designing the guide RNAs. As we showed in our results, this 9 approach could be applied for any gene of interest. Finally, using this system, we demonstrated a 10 highly programmable control of metabolic fluxes when using yeast to produce versatile 11 chemicals.
13
Results
14
Gene activation and repression by using a CRISPR-based transcriptional regulator.
15
The CRISPR-based transcriptional regulator is composed of a codon-optimized, catalytically were expressed without guide RNA. As summarized in Fig. 1B and Fig. 1C RNAs (94.2%) that were positioned in the promoter region led to gene up-regulation or no effect.
22
We also evaluated whether different PAM sites (i.e., 3'AGG, 3'TGG, 3'CGG, 3'GGG) could with guide RNAs) and the ones that were not. As shown in Fig. S1 , 131 out of the 138 tests 7 showed no significant difference (p>0.05) on cell growth rate when being compared to that of the 8 control strain, indicating a minimal metabolic burden when using only one synthetic protein for 9 transcriptional regulation. between observed and simulated fold changes (Fig. S2B ). This clearly indicated that the 1 biomolecular interactions of RNA-protein and DNA-protein in the dCas9-VP64 system were 2 highly nonlinear, which cannot be captured by the simple linear regression model.
3
We then used machine learning to derive an empirical model to quantitatively predict the 4 nonlinear correlation between design parameters and transcriptional regulation by dCas9-VP64.
5
As a data-driven modeling approach, machine learning is advantageous than linear model in automatically adjust the nodes and connections of the decision tree to optimize the fitting 26, 27 .
16
Using the 138 pairwise data collected from the synthetic genetic cassettes (i.e., TEF1p-GFP,
17
TPI1p-mCherry, PDC1p-Sapphire, and PGK1p-Venus), we found that the prediction accuracy (Fig. 2C ).
20
Also, we found that the prediction accuracy of our machine-learning algorithm was improved
21
with the enlargement of data size (Fig. 2D) the predicted and the measured gene expressions reaching 0.87 (Fig. 2E ). This success 10 demonstrated that our data-driven model could be generally applicable to guide the biomolecular 11 design of dCas9-VP64 system to achieve customized gene regulation.
12
We also packaged our machine-learning algorithm into an open-source toolbox ( reprogrammed using our CRISPR-based transcription regulator. We chose the highly branched 1 bacterial violacein biosynthetic pathway as our model pathway 28 (Fig. 3A) of the constructs that were used in this study were listed in Table S1 . Strains constructed in this 17 study were listed in Table S2 . Table S3 and Table S4 .
5
Qualitative analysis of key parameters. The exponential fold changes of different gRNA 6 designs have been separated into two categories, the promoter region (location < 0, n = 52) and 7 the gene coding region (location > 0, n = 86). The unpaired two-tail t-test was used to calculate 8 the significance of the fold changes between these two groups. For the analysis of the PAM type, 9 the same t-test was used for each PAM types (n AGG = 42, n TGG = 69, n CGG = 21, n GGG = 6).
10
Modeling. The multiple linear regression model was implemented by the "regress" command in Competing financial interests.
The authors do not have any conflicts of financial interests. experimentally measured gene regulations on Eno2p-tdTomato cassette subject to dCas9-VP64 1 regulation.
2 Figure S3 . Screenshot of CRISTINES software with a demo sequence.
3 Table S1 . DNA sequences and plasmids used in this study.
4 Table S2 . Strains used in this study.
5 Table S3 . Key parameters of guide RNAs used in this study.
6 Table S4 . Key parameters of guide RNAs used in validation experiments (Eno2p-tdTomato).
7 Table S5 . Binary regression decision tree model.
8 Table S6 . Measured and predicted concentrations of products from violacein pathway 
